Hydroxyproline metabolism in mouse models of primary hyperoxaluria

American Journal of Physiology - Renal Physiology

Volumn 302, Issue 6, 2012, Pages

  Knight, John ^a   Holmes, Ross P ^a   Cramer, Scott D ^a,b   Takayama, Tatsuya ^a   Salido, Eduardo ^c  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Calcium oxalate crystals; Nephrocalcinosis; Oxalate

Indexed keywords

ALANINE GLYOXYLATE AMINOTRANSFERASE; CYSTATIN C; GLYCOLIC ACID; HYDROXYPROLINE; HYDROXYPYRUVATE REDUCTASE; OXALIC ACID;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPEROXALURIA; KIDNEY; KIDNEY CALCIFICATION; KIDNEY DYSFUNCTION; MOUSE; NONHUMAN; OXALOSIS 1; PATHOLOGY; PRIMARY HYPEROXALURIA TYPE 2; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 84858273945     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00473.2011     Document Type: Article

References (19)

1. Adams MR, Golden DL, Franke AA, Potter SM, Smith HS, Anthony MS. Dietary soy beta-conglycinin (7S globulin) inhibits atherosclerosis in mice. J Nutr 134: 511-516, 2004.
2. Cramer SD, Ferree PM, Lin K, Milliner DS, Holmes RP. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with Primary Hyperoxaluria Type II. Hum Mol Genet 11: 2063-2069, 1999.
3. Danpure CJ. Primary hyperoxaluria. In: The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver CR, Beaudet AL, Sly WS, Vallee D, Childs B, Kinzler KW, and Vogelstein B. New York: McGraw-Hill, 2001, p. 3323-3367.
4. Frendeus KH, Wallin H, Janciauskiene S, Abrahamson M. Macrophage responses to interferon-gamma are dependent on cystatin C levels. Int J Biochem Cell Biol 41: 2262-2269, 2009.
5. Harris AH, Freel RW, Hatch M. Serum oxalate in human beings and rats as determined with the use of ion chromatography. J Lab Clin Med 144: 45-52, 2004.
6. Holmes RP, Assimos DG. Glyoxylate synthesis, and its modulation and its influence on oxalate synthesis. J Urol 160: 1617-1624, 1998.
7. Hoppe B, Beck BB, Milliner DS. The primary hyperoxalurias. Kidney Int 75: 1264-1271, 2009.
8. Kaplon DM, Penniston KL, Darriet C, Crenshaw TD, Nakada SY. Hydroxyproline-induced hyperoxaluria using acidified and traditional diets in the porcine model. J Endourol 24: 355-359, 2010.
9. Khan SR, Glenton PA. Experimental induction of calcium oxalate nephrolithiasis in mice. J Urol 184: 1189-1196, 2010.
10. Khan SR, Glenton PA, Byer KJ. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline. Kidney Int 70: 914-923, 2006.
11. Knight J, Assimos DG, Easter L, Holmes RP. Metabolism of fructose to oxalate and glycolate. Horm Metab Res 42: 868-873, 2010.
12. Knight J, Holmes RP. Mitochondrial hydroxyproline metabolism: implications for primary hyperoxaluria. Am J Nephrol 25: 171-175, 2005.
13. Knight J, Jiang J, Assimos DG, Holmes RP. Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Kidney Int 70: 1929-1934, 2006.
14. Mandel NS, Henderson JD, Hung LY, Wille DF, Wiessner JH. A porcine model of calcium oxalate kidney stone disease. J Urol 171: 1301-1303, 2004.
15. Phang JM, Hu CA, Valle D. Disorders of proline and hydroxyproline metabolism. In: The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver CR, Beaudet AL, Sly WS, Vallee D, Childs B, Kinzler KW, and Vogelstein B. New York: McGraw-Hill, 2001, p. 1821-1838.
16. Salido EC, Li XM, Lu Y, Wang X, Santana A, Roy-Chowdhury N, Torres A, Shapiro LJ, Roy-Chowdhury J. Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer. Proc Natl Acad Sci USA 103: 18249-18254, 2006.
17. Seronie-Vivien S, Delanaye P, Pieroni L, Mariat C, Froissart M, Cristol JP. Cystatin C: current position and future prospects. Clin Chem Lab Med 46: 1664-1686, 2008.
18. Thornalley PJ. Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 31: 1343-1348, 2003.
19. Yasue T. Histochemical identification of calcium oxalate. Acta Histochem Cytochem 2: 83-95, 1969.